Top 20 Shareholders April 2023
Top_Holders_Report (23)
MND Trial Successfully Completes Second Patient Cohort
MND Trial Successfully Completes Second Patient Cohort (final)(RA)
Appendix 4C and Quarterly Update
Appendix 4C and Quarterly Update – March 2023
Canine Trial Update
PAA Canine Trial Update – April 2023 (final)
Arrival of additional MPL tablets
Arrival of additional MPL tablets SW RB (1)
PharmAust launches international CEO search
PharmAust launches international CEO Search (final)
PharmAust Roadshow Presentation
PharmAust Roadshow Presentation
Top 20 Shareholders March 2023
Top_Holders_Report (24)
MND Trial Completes Enrolment of Cohort 2
MND Trial Completes Enrolment of Cohort 2 – (final)
Stable Patient in MND trial reaches 6-months on MPL
Stable Patient in MND trial reaches 6-months on MPL